One page, thousands of outlets. See who else covered it.
AstraZeneca on Monday reported successes in two late-stage trials in different forms of lung cancer — one with a two-drug combination of Tagrisso and Orpathys and another with its blockbuster antibody-drug conjugate Enhertu. Taken together with ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
GEN asked leaders in biomanufacturing: What technologies do you use to carry out effective impurity removal at specific points throughout upstream and downstream processing to ensure product quality…
Summit Therapeutics and Akeso’s next-generation cancer drug ivonescimab earned an approval in China last week for first-line patients with certain forms of lung cancer.
[Vanguard] ...Experts warn: Ignorance, poor awareness fueling discrimination, delay diagnosis
The U.S. Federal Trade Commission has opened an antitrust investigation into Epic and is looking into its data-sharing practices, Reuters reported on Friday.
People with ADHD are unusually sensitive to hormone shifts. Psychiatrists have started to pay attention, creating strategies to address the intense emotions and cognitive challenges caused by these…
(MedPage Today) -- Extending the shelf life of platelets with refrigeration didn't hurt their hemostatic function for people undergoing complex cardiac surgery, the landmark CHIPS trial found.